A Randomized Blinded Prospective Trial Comparing PEG 3350 (MiraLAX®) with Bisacodyl Pretreatment versus PEG 3350 (MiraLAX®) with Lubiprostone Pretreatment versus PEG 3350 (MiraLAX®) without Pretreatment versus PEG 3350 (Golytely®) for Bowel Cleansing Prior to Colonoscopy: 2010 Presidential Poster

Autor:	Joel Z Stengel, Mark C. Liu, Michael Hjelkrem, David Jones
Rok vydání:	2010
Předmět:	medicine.medical_specialty Hepatology medicine.diagnostic_test business.industry Gastroenterology Colonoscopy Lubiprostone Prospective trial Internal medicine PEG ratio medicine Bowel cleansing Bisacodyl business medicine.drug
Zdroj:	American Journal of Gastroenterology. 105:S138
ISSN:	0002-9270
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e83f7a52278b92f71d721faf2d20e60b https://doi.org/10.14309/00000434-201010001-00375 Zobrazit plný text záznamu